16/01/2026
DNA methylation mapping of plasma cell-free DNA (cfDNA) has emerged as a promising clinical tool. Choosing the right analytical method is crucial for working with limited amount of sample, ensuring cost-effectiveness, and supporting clinical translation. Here we compare key technology in liquid biopsy epigenetics in terms of cost, accuracy, and reproducibility to guide transnational research in this space. This is an active focus of my lab. . Check it out:
This link will take you to a page that’s not on LinkedIn